Table 2.
Comparison of predicted outcome with age and sex matched population of those who survived 6 months after transplant [6].
(PBC primary biliary cholangitis).
| Risk factor | Life expectancy of allograft recipients (years) | National population survival (years) | Difference | |
|---|---|---|---|---|
| Sex | Male | 18.3 | 27.6 | 9.3 |
| Female | 26.8 | 31.1 | 4.3 | |
| Age range (year) | 17–34 | 28.8 | 51.2 | 22.4 |
| 35–44 | 24.6 | 38.3 | 13.7 | |
| 45–54 | 25.3 | 29.7 | 4.4 | |
| 55–64 | 19.5 | 21.8 | 2.3 | |
| ≥65 | 12.2 | 16.2 | 4.0 | |
| Indication | PBC | 35.8 | 29.2 | −6.6 |
| Autoimmune hepatitis | 24.5 | 29.2 | 4.7 | |
| Sclerosing cholangitis | 26.0 | 29.2 | 5.0 | |
| Alcohol related liver disease | 15.0 | 29.2 | 14.2 | |
| Cancer | 5.3 | 29.2 | 23.9 | |